Mackenzie Financial’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,047
Closed -$362K 1611
2022
Q4
$362K Buy
+8,047
New +$364K ﹤0.01% 1027
2022
Q2
Sell
-2,200
Closed -$256K 1544
2022
Q1
$256K Buy
+2,200
New +$257K ﹤0.01% 1196

Other funds holding TNDM

Mackenzie Financial's TNDM Position: Q1 2023 in Review

Mackenzie Financial sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 8,047 shares — an estimated $362K sold.

Mackenzie Financial first reported a position in TNDM in Q1 2022 and held it in 2 quarters. The position peaked at $362K in Q4 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • Mackenzie Financial reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • Mackenzie Financial sold 8,047 Tandem Diabetes Care shares in Q1 2023, an estimated $362K.
  • Mackenzie Financial first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 2 quarters.
  • Mackenzie Financial's Tandem Diabetes Care position peaked at $362K in Q4 2022.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Mackenzie Financial's 13F filing for Q1 2023, filed 24 Apr 2023.